Peroxiredoxin 1 Stimulates Endothelial Cell Expression of VEGF via TLR4 Dependent Activation of HIF-1α
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Peroxiredoxin 1 Stimulates Endothelial Cell Expression of VEGF via TLR4 Dependent Activation of HIF-1α
Authors
Keywords
Transcription factors, Endothelial cells, Luciferase, Transfection, Inflammation, Phosphorylation, Toll-like receptors, Macrophages
Journal
PLoS One
Volume 7, Issue 11, Pages e50394
Publisher
Public Library of Science (PLoS)
Online
2012-11-22
DOI
10.1371/journal.pone.0050394
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Hypoxia and Hypoxia-Inducible Factor-1 Modulate Lipopolysaccharide-Induced Dendritic Cell Activation and Function
- (2014) J. Jantsch et al. JOURNAL OF IMMUNOLOGY
- Peroxiredoxin 1 Controls Prostate Cancer Growth through Toll-Like Receptor 4-Dependent Regulation of Tumor Vasculature
- (2011) J. R. Riddell et al. CANCER RESEARCH
- NFκB inhibition and more: A side-by-side comparison of the inhibitors of IKK and proteasome
- (2011) Eugene S. Kandel CELL CYCLE
- Influence of the tumor microenvironment on angiogenesis
- (2011) Sarah JL Payne et al. Future Oncology
- Immunity, Inflammation, and Cancer
- (2010) Sergei I. Grivennikov et al. CELL
- Deciphering the complexity of Toll-like receptor signaling
- (2010) Renato Ostuni et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Effects of TLR Agonists on the Hypoxia-Regulated Transcription Factor HIF-1α and Dendritic Cell Maturation under Normoxic Conditions
- (2010) Rolf Spirig et al. PLoS One
- Induction of peroxiredoxin I gene expression by LPS involves the Src/PI3K/JNK signalling pathway
- (2009) Antje Bast et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Oxidative stress in prostate cancer
- (2009) Lakshmipathi Khandrika et al. CANCER LETTERS
- Inflammation and oncogenesis: a vicious connection
- (2009) Sergei I Grivennikov et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- VEGF elicits epithelial-mesenchymal transition (EMT) in prostate intraepithelial neoplasia (PIN)-like cells via an autocrine loop
- (2009) Oscar Gonzalez-Moreno et al. EXPERIMENTAL CELL RESEARCH
- Hypoxic stress up-regulates the expression of Toll-like receptor 4 in macrophages via hypoxia-inducible factor
- (2009) So Young Kim et al. IMMUNOLOGY
- Peroxiredoxin 1 Stimulates Secretion of Proinflammatory Cytokines by Binding to TLR4
- (2009) J. R. Riddell et al. JOURNAL OF IMMUNOLOGY
- Differential regulation of HIF-1α isoforms in murine macrophages by TLR4 and adenosine A2A receptor agonists
- (2009) Madhuri Ramanathan et al. JOURNAL OF LEUKOCYTE BIOLOGY
- LPS Induces Hypoxia-Inducible Factor 1 Activation in Macrophage-Differentiated Cells in a Reactive Oxygen Species–Dependent Manner
- (2008) Kenichiro Nishi et al. ANTIOXIDANTS & REDOX SIGNALING
- HIF-1 regulates epithelial inflammation by cell autonomous NF B activation and paracrine stromal remodeling
- (2008) M. Scortegagna et al. BLOOD
- Androgen Receptor Is Causally Involved in the Homeostasis of the Human Prostate Endothelial Cell
- (2008) Alejandro Godoy et al. ENDOCRINOLOGY
- Fasudil-induced hypoxia-inducible factor-1α degradation disrupts a hypoxia-driven vascular endothelial growth factor autocrine mechanism in endothelial cells
- (2008) Keiko Takata et al. MOLECULAR CANCER THERAPEUTICS
- NF-κB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1α
- (2008) Jordi Rius et al. NATURE
- Cancer-related inflammation
- (2008) Alberto Mantovani et al. NATURE
- Precursor lesions to prostatic adenocarcinoma
- (2008) Jonathan I. Epstein VIRCHOWS ARCHIV
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started